Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice

Abstinence symptoms in cannabis-dependent individuals are believed to contribute to the maintenance of regular marijuana use. However, there are currently no medications approved by the FDA to treat cannabis-related disorders. The only treatment currently shown consistently to alleviate cannabinoid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Schlosburg, Joel E., Carlson, Brittany L. A., Ramesh, Divya, Abdullah, Rehab A., Long, Jonathan Z., Cravatt, Benjamin F., Lichtman, Aron H.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2009
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2691470/
https://ncbi.nlm.nih.gov/pubmed/19430909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-009-9110-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares